Clinical trials
Phase 1 Genital Neoplasms, Female trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Completed | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AA Secord | 1 |
| Advaxis, Inc. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Arsenal Biosciences, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| University of Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Neoplasms, Female | 6 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Uterine Cervical Neoplasms | 4 |
| Fallopian Tube Neoplasms | 3 |
| Neoplasms | 3 |
| Uterine Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.